AVAnT1A study: Investigating early COVID-19 vaccination and type 1 diabetes risk in children Post author: Post published:May 8, 2024 Post category:uncategorized Type 1 diabetes is an autoimmune disease that leads to disrupted glucose metabolism. It requires lifelong insulin therapy. You Might Also Like AI-READI consortium launches groundbreaking diabetes data study November 8, 2024 JMU Würzburg professor wins ERC Consolidator Grant to advance research on ferroptosis November 23, 2023 New insights into early Huntington’s disease mechanisms November 4, 2024
JMU Würzburg professor wins ERC Consolidator Grant to advance research on ferroptosis November 23, 2023